Clinical Trial Update: Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type II Diabetes Mellitus [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the efficacy and safety of Subetta as part of a combined treatment for Type II diabetes mellitus has completed enrollment with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Subetta

Snippet

Sponsor: Materia Medica Holding | Conditions: Type II Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2019-03-04